Close
Back to PTGX Stock Lookup
Pages: 1 2 3 4 5 6 »» Last Page

Protagonist Therapeutics (PTGX) –

Apr 19, 2024 08:06 PM Form 4 Protagonist Therapeutics For: Apr 18 Filed by: Ali Asif
Apr 16, 2024 09:00 AM Turnstone Biologics Appoints William Waddill to its Board of Directors
Apr 12, 2024 04:31 PM Form PRE 14A Protagonist Therapeutics For: Jun 20
Apr 2, 2024 08:30 PM Form 4 Protagonist Therapeutics For: Apr 01 Filed by: PATEL DINESH V PH D
Apr 1, 2024 04:09 PM Form 144 Protagonist Therapeutics Filed by: PATEL DINESH V PH D
Mar 11, 2024 08:01 PM Form 4 Protagonist Therapeutics For: Mar 07 Filed by: SELICK HAROLD E
Mar 1, 2024 08:47 PM Form 4 Protagonist Therapeutics For: Mar 01 Filed by: PATEL DINESH V PH D
Mar 1, 2024 08:46 PM Form 4 Protagonist Therapeutics For: Mar 01 Filed by: Waddill William D.
Mar 1, 2024 08:46 PM Form 4 Protagonist Therapeutics For: Feb 29 Filed by: Ali Asif
Mar 1, 2024 08:28 PM Form 144 Protagonist Therapeutics Filed by: Ali Asif
Mar 1, 2024 04:32 PM Form 144 Protagonist Therapeutics Filed by: Waddill William D.
Mar 1, 2024 04:28 PM Form 144 Protagonist Therapeutics Filed by: PATEL DINESH V PH D
Feb 29, 2024 05:49 PM Form 144 Protagonist Therapeutics Filed by: Ali Asif
Feb 28, 2024 08:03 PM Form 4 Protagonist Therapeutics For: Feb 26 Filed by: PATEL DINESH V PH D
Feb 28, 2024 08:01 PM Form 4 Protagonist Therapeutics For: Feb 26 Filed by: Gupta Suneel
Feb 28, 2024 07:08 AM Protagonist Therapeutics (PTGX) PT Raised to $37 at JPMorgan
Feb 28, 2024 02:15 AM Protagonist Therapeutics (PTGX) Tops Q4 EPS by 58c
Feb 27, 2024 04:54 PM Form S-8 Protagonist Therapeutics
Feb 27, 2024 04:44 PM Form 10-K Protagonist Therapeutics For: Dec 31
Feb 27, 2024 04:15 PM Form 8-K Protagonist Therapeutics For: Feb 27
Feb 27, 2024 04:05 PM Protagonist Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Feb 21, 2024 05:03 PM Protagonist Therapeutics (PTGX) announces positive Phase 2 REVIVE results published in NEJM
Feb 21, 2024 05:00 PM New England Journal of Medicine Publishes Results of Positive Randomized Phase 2 REVIVE Trial of Rusfertide in Treatment of Polycythemia Vera
Feb 20, 2024 08:01 PM Form 4 Protagonist Therapeutics For: Feb 15 Filed by: PATEL DINESH V PH D
Feb 20, 2024 04:05 PM Protagonist Therapeutics Reports Granting of Inducement Awards
Feb 14, 2024 04:59 PM Form SC 13G/A Protagonist Therapeutics Filed by: CITADEL ADVISORS LLC
Feb 14, 2024 09:32 AM Form SC 13G/A Protagonist Therapeutics Filed by: BIOTECHNOLOGY VALUE FUND L P
Feb 14, 2024 07:48 AM Form SC 13G/A Protagonist Therapeutics Filed by: RTW INVESTMENTS, LP
Feb 14, 2024 07:15 AM Form SC 13G/A Protagonist Therapeutics Filed by: Point72 Asset Management, L.P.
Feb 13, 2024 05:18 PM Form SC 13G/A Protagonist Therapeutics Filed by: VANGUARD GROUP INC
Feb 7, 2024 05:03 PM Protagonist Therapeutics (PTGX) Reports Publication of Efficacy and Safety Data of Targeted Oral Peptide JNJ-2113
Feb 7, 2024 05:00 PM New England Journal of Medicine Publishes Efficacy and Safety Data of Targeted Oral Peptide JNJ-2113 in a Phase 2b Moderate-To-Severe Plaque Psoriasis Study
Feb 7, 2024 07:42 AM Form SC 13G/A Protagonist Therapeutics Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
Feb 2, 2024 09:20 AM Form SC 13G/A Protagonist Therapeutics Filed by: Farallon Capital Partners, L.P.
Jan 31, 2024 04:09 PM Takeda (TAK) and Protagonist Therapeutics (PTGX) Enter Global License and Collaboration Agreement for Rusfertide
Jan 31, 2024 04:05 PM Form 8-K Protagonist Therapeutics For: Jan 31
Jan 31, 2024 04:05 PM Takeda and Protagonist Therapeutics, Inc. Enter into Worldwide License and Collaboration Agreement for Rusfertide, a Late-Stage Rare Hematology Asset
Jan 24, 2024 02:29 PM Form SC 13G/A Protagonist Therapeutics Filed by: BlackRock Inc.
Jan 23, 2024 10:56 AM Form SC 13G/A Protagonist Therapeutics Filed by: STATE STREET CORP
Jan 18, 2024 08:01 PM Form 4 Protagonist Therapeutics For: Jan 16 Filed by: MOLINA ARTURO MD
Jan 18, 2024 08:00 PM Form 4 Protagonist Therapeutics For: Jan 16 Filed by: Ali Asif
Jan 16, 2024 08:02 AM Form 8-K Protagonist Therapeutics For: Jan 09
Jan 11, 2024 08:01 PM Form 4 Protagonist Therapeutics For: Jan 09 Filed by: Gupta Suneel
Jan 9, 2024 05:26 PM Form 144 Protagonist Therapeutics Filed by: Gupta Suneel
Jan 8, 2024 08:01 AM Form 8-K Protagonist Therapeutics For: Jan 08
Jan 4, 2024 08:18 PM Form 4 Protagonist Therapeutics For: Jan 02 Filed by: Waddill William D.
Jan 4, 2024 08:17 PM Form 4 Protagonist Therapeutics For: Jan 02 Filed by: O'Dowd Sarah A
Jan 4, 2024 08:16 PM Form 4 Protagonist Therapeutics For: Jan 02 Filed by: Gupta Suneel
Jan 4, 2024 08:14 PM Form 4 Protagonist Therapeutics For: Jan 02 Filed by: SELICK HAROLD E
Jan 4, 2024 08:14 PM Form 4 Protagonist Therapeutics For: Jan 02 Filed by: Williams Lewis T
Pages: 1 2 3 4 5 6 »» Last Page

Back to PTGX Stock Lookup